Inhibition of mammalian target of rapamycin (mTOR) in epidermis
Cutaneous squamous cell carcinoma (cSCC) is one of the most common Caucasian skin cancers and is particularly prevalent following chronic ultraviolet (UV) radiation exposure and in immunosuppressed patients. Recent use of rapamycin as an immunosuppressant significantly reduces SCC after organ transp...
Main Author: | Sully, Katherine L. |
---|---|
Published: |
Queen Mary, University of London
2012
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.566660 |
Similar Items
-
Resistance mechanisms to mTOR inhibition in renal cancer
by: Earwaker, Philip L.
Published: (2015) -
mTOR inhibition as a therapeutic strategy in tuberous sclerosis or sporadic lymphangioleiomyomatosis
by: Davies, David Mark
Published: (2011) -
Design and synthesis of small-molecule inhibitors of two cancer targets : mTor and MDM2/p53
by: Revill, Charlotte Holly
Published: (2012) -
Neuregulin3 alters cell fate in the epidermis and mammary gland
by: Panchal, Heena
Published: (2008) -
Regulation of mammalian autophagy via mAtg9 and p38IP
by: Webber, J. L.
Published: (2010)